〔Abstract〕 Objective To explore the effect of Qiju Danggui Shaoyao decoction combined with labetalol in the treatment of hypertensive disorders during pregnancy (HDCP). Methods Ninety patients with HDCP admitted to Tianshui Fourth People's Hospital from January 2021 to October 2023 were randomly divided into an observation group and a control group, with 45 patients in each group. The control group patients were treated with labetalol, while the observation group patients were treated with Qiju Danggui Shaoyao decoction combined with labetalol. The relevant clinical indicators of the two groups of patients were compared. Results The total effective rate of the observation group (93.88 %) was higher than than of the control group (77.78 %), and the difference was statistically significant (P < 0.05). After treatment, the diastolic blood pressure, systolic blood pressure, and positive rate of urinary protein in the observation group were all lower than those in the control group, and the differences were statistically significant (P < 0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P ＞ 0.05). The incidence of neonatal adverse outcomes and maternal adverse outcomes were lower than those in the control group, and the differences were statistically significant (P < 0.05). Conclusion The treatment of Qiju Danggui Shaoyao decoction combined with labetalol for HDCP patients has significant efficacy, which can reduce the blood pressure level and urinary protein positive rate, with high safety. It can also reduce the incidence of adverse outcomes in newborns and pregnant women.